Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
4.050
-0.030 (-0.74%)
At close: Jul 21, 2025, 4:00 PM
4.120
+0.070 (1.73%)
After-hours: Jul 21, 2025, 7:55 PM EDT
Altimmune Stock Forecast
Stock Price Forecast
The 6 analysts that cover Altimmune stock have a consensus rating of "Strong Buy" and an average price target of $18.2, which forecasts a 349.38% increase in the stock price over the next year. The lowest target is $12 and the highest is $26.
Price Target: $18.2 (+349.38%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Altimmune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $25 → $15 | Buy | Maintains | $25 → $15 | +270.37% | Jul 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +196.30% | Jun 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +196.30% | Apr 3, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $25 | Buy | Reiterates | $25 | +517.28% | Apr 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +196.30% | Mar 18, 2025 |
Financial Forecast
Revenue This Year
5.69K
from 20.00K
Decreased by -71.57%
Revenue Next Year
28.86M
from 5.69K
Increased by 507,435.66%
EPS This Year
-1.33
from -1.34
EPS Next Year
-1.45
from -1.33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21,000 | 210.0M | 135.1M | ||
| Avg | 5,686 | 28.9M | 23.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.0% | 3,692,986.9% | 368.1% | ||
| Avg | -71.6% | 507,435.7% | -17.2% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.22 | -0.48 | -0.78 | ||
| Avg | -1.33 | -1.45 | -1.28 | ||
| Low | -1.59 | -2.26 | -1.84 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.